labetalol has been researched along with bradykinin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, G; Gress, TM; Lerch, MM; Pfaff, D; Turi, S; Weidenbach, H | 1 |
| Blaschke, TF; Haefeli, WE; Hoffman, BB; Kongpatanakul, S; Srivastava, N | 1 |
2 other study(ies) available for labetalol and bradykinin
| Article | Year |
|---|---|
Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis.
Topics: Acute Disease; Animals; Arginine; Bradykinin; Catecholamines; Ceruletide; Edema; Labetalol; Male; Microcirculation; Microscopy, Electron, Scanning; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Pancreas; Pancreatitis; Phenylephrine; Rats; Rats, Wistar | 1995 |
Lack of role of endothelium-derived relaxing factor in effects of alpha-adrenergic agonists in cutaneous veins in humans.
Topics: Adrenergic alpha-Agonists; Adult; Angiotensin II; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hand; Humans; Labetalol; Male; Methylene Blue; Nitric Oxide; Skin; Vasoconstriction; Veins | 1993 |